Guidance for statistics in regulatory affairs refers to documents and recommendations provided by regulatory agencies to help ensure the proper application of statistical methods in the development, approval, and monitoring of products, particularly in the pharmaceutical and biotechnology sectors. These guidelines aim to provide clarity on best practices in statistical design, analysis, and interpretation of data submitted for regulatory approval.
Articles by others on the same topic
There are currently no matching articles.